These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33224881)

  • 1. Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors.
    Gachechiladze M; Skarda J; Bouchalova K; Soltermann A; Joerger M
    Front Oncol; 2020; 10():581217. PubMed ID: 33224881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.
    Manic G; Obrist F; Sistigu A; Vitale I
    Mol Cell Oncol; 2015; 2(4):e1012976. PubMed ID: 27308506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.
    Jang SH; Lim JW; Morio T; Kim H
    Free Radic Biol Med; 2012 Feb; 52(3):607-615. PubMed ID: 22178412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.
    Deng S; Vlatkovic T; Li M; Zhan T; Veldwijk MR; Herskind C
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer.
    Tomasini PP; Guecheva TN; Leguisamo NM; Péricart S; Brunac AC; Hoffmann JS; Saffi J
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
    Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
    Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ATR in cancer medicine.
    Sundar R; Brown J; Ingles Russo A; Yap TA
    Curr Probl Cancer; 2017; 41(4):302-315. PubMed ID: 28662958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.
    Takeuchi M; Tanikawa M; Nagasaka K; Oda K; Kawata Y; Oki S; Agapiti C; Sone K; Miyagawa Y; Hiraike H; Wada-Hiraike O; Kuramoto H; Ayabe T; Osuga Y; Fujii T
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805725
    [No Abstract]   [Full Text] [Related]  

  • 13. Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.
    Gourley C; Balmaña J; Ledermann JA; Serra V; Dent R; Loibl S; Pujade-Lauraine E; Boulton SJ
    J Clin Oncol; 2019 Sep; 37(25):2257-2269. PubMed ID: 31050911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.
    Huang RX; Zhou PK
    Signal Transduct Target Ther; 2020 May; 5(1):60. PubMed ID: 32355263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the Trinity of ATM, ATR, and DNA-PK: Multiple Kinases Shape the DNA Damage Response in Concert With RNA Metabolism.
    Burger K; Ketley RF; Gullerova M
    Front Mol Biosci; 2019; 6():61. PubMed ID: 31428617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
    Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
    J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
    Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
    PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes.
    Mavroeidi D; Georganta A; Panagiotou E; Syrigos K; Souliotis VL
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between DNA repair and autophagy in cancer therapy.
    Zhang D; Tang B; Xie X; Xiao YF; Yang SM; Zhang JW
    Cancer Biol Ther; 2015; 16(7):1005-13. PubMed ID: 25985143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR.
    Wang F; Jin S; Mayca Pozo F; Tian D; Tang X; Dai Y; Yao X; Tang J; Zhang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1339-1350. PubMed ID: 35530159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.